SWA
Sutton Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $38.7K | Buy |
47
+13
| +38% | +$10.7K | 0.02% | 261 |
|
|
2023
Q2 | $24.4K | Hold |
34
| – | – | 0.01% | 322 |
|
|
2023
Q1 | $27.9K | Sell |
34
-2
| -6% | -$1.64K | 0.01% | 264 |
|
|
2022
Q4 | $26K | Sell |
36
-3
| -8% | -$2.17K | 0.01% | 592 |
|
|
2022
Q3 | $26.9K | Buy |
39
+3
| +8% | +$2.07K | 0.01% | 563 |
|
|
2022
Q2 | $21.3K | Hold |
36
| – | – | 0.01% | 655 |
|
|
2022
Q1 | $25.1K | Buy |
36
+3
| +9% | +$2.1K | 0.01% | 635 |
|
|
2021
Q4 | $20.8K | Hold |
33
| – | – | 0.01% | 683 |
|
|
2021
Q3 | $20K | Sell |
33
-2
| -6% | -$1.21K | 0.01% | 696 |
|
|
2021
Q2 | $19.5K | Hold |
35
| – | – | 0.01% | 709 |
|
|
2021
Q1 | $16.6K | Sell |
35
-1
| -3% | -$473 | 0.01% | 725 |
|
|
2020
Q4 | $17.4K | Buy |
36
+4
| +13% | +$1.93K | 0.01% | 656 |
|
|
2020
Q3 | $17.9K | Hold |
32
| – | – | 0.01% | 575 |
|
|
2020
Q2 | $20K | Hold |
32
| – | – | 0.01% | 534 |
|
|
2020
Q1 | $15.6K | Buy |
32
+8
| +33% | +$3.91K | 0.01% | 540 |
|
|
2019
Q4 | $9.01K | Hold |
24
| – | – | ﹤0.01% | 848 |
|
|
2019
Q3 | $6.66K | Buy |
24
+1
| +4% | +$277 | ﹤0.01% | 881 |
|
|
2019
Q2 | $7.2K | Sell |
23
-3
| -12% | -$939 | ﹤0.01% | 847 |
|
|
2019
Q1 | $10.7K | Hold |
26
| – | – | 0.01% | 772 |
|
|
2018
Q4 | $9.71K | Buy |
26
+3
| +13% | +$1.12K | 0.01% | 754 |
|
|
2018
Q3 | $9.29K | Hold |
23
| – | – | 0.01% | 802 |
|
|
2018
Q2 | $7.94K | Hold |
23
| – | – | 0.01% | 871 |
|
|
2018
Q1 | $7.92K | Sell |
23
-36
| -61% | -$12.4K | 0.01% | 867 |
|
|
2017
Q4 | $22.2K | Sell |
59
-2
| -3% | -$752 | 0.02% | 519 |
|
|
2017
Q3 | $27.3K | Buy |
61
+2
| +3% | +$894 | 0.02% | 438 |
|
|
2017
Q2 | $29K | Hold |
59
| – | – | 0.02% | 414 |
|
|
2017
Q1 | $22.9K | Sell |
59
-3
| -5% | -$1.16K | 0.02% | 470 |
|
|
2016
Q4 | $22.8K | Buy |
62
+3
| +5% | +$1.1K | 0.02% | 453 |
|
|
2016
Q3 | $23.7K | Buy |
59
+2
| +4% | +$804 | 0.02% | 415 |
|
|
2016
Q2 | $19.9K | Buy |
57
+36
| +171% | +$12.6K | 0.02% | 448 |
|
|
2016
Q1 | $7.57K | Buy |
+21
| New | +$7.57K | 0.01% | 660 |
|